FGF-23, vascular calcification, and cardiovascular diseases in chronic hemodialysis patients

International Urology and Nephrology

Volumn 46, Issue 1, 2014, Pages 121-128

  Moldovan, Diana ^a,d   Moldovan, Ioan ^b   Rusu, Crina ^a   Kacso, Ina ^a   Patiu, Ioan Mihai ^c   Gherman Caprioara, Mirela ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Scandia Imagistica Cluj Napoca   (Romania)

^c Nefromed Dialysis Centers   (Romania)

^d Mihai Manasia Nephrology Clinic   (Romania)

Author keywords

Cardiovascular diseases; Chronic hemodialysis; Fibroblast growth factor 23; Vascular calcification

Indexed keywords

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84893856737     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0422-2     Document Type: Article

References (38)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208-2218 (Pubitemid 39031360)
2. Adragao T, Pires A, Lucas C et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transpl 19(6):1480-1488 (Pubitemid 38786742)
3. Moldovan D, Rusu C, Patiu IM et al (2010) Could the serum parathormone be a predictive marker for peripheral vascular calcification in chronic dialysis patients? Acta Endo (Buc) 1:43-55
4. Druke T (2008) Arterial intima and media calcification: distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol 3:1583-1584
5. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18(9):1731-1740 (Pubitemid 37098542)
6. Razzaque MS (2009) The FGF23-klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5:611-619
7. Mirza MA, Larsson A, Melhus H et al (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207:546-551
8. Mirza MA, Hansen T, Johansson L et al (2009) Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transpl 24:3125-3131
9. Bernheim J, Benchetrit S (2011) The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases. Nephrol Dial Transpl 26(8):2433-2438
10. Jean G, Bresson E, Terrat JC et al (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transpl 24:948-955
11. Nasrallah MM, El-Shehaby AR, Salem MM et al (2010) Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transpl 25(8):2679-2685
12. Moldovan D, Moldovan I, Rusu C et al (2011) Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them? Int Urol Nephrol 43:1179-1186
13. Seiler S, Reichart B, Roth D, Seibert E et al (2010) FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transpl 25(12):3983-3989
14. Kirkpantur A, Balci M, Gurbuz OA et al (2011) Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transpl 26(4):1346-1354
15. Gutierrez OM, Januzzi JL, Isakova T et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545-2552
16. Hsu HJ, Wu MS (2009) Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337:116-122
17. Oliveira RB, Cancela ALE, Graciolli FG et al (2010) Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: a New Target in CKD-MBD Therapy? Clin J Am Soc Nephrol 5:286-291
18. Ford ML, Smith ER, Tomlinson LA et al (2012) FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Nephrol Dial Transpl 27(2):727-733
19. Shimada T, Kakitani M, Yamazaki Y et al (2004) Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568 (Pubitemid 38542505)
20. Roos M, Lutz J, Salmhofer H et al (2008) Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol 68(4):660-665 (Pubitemid 351388700)
21. Fliser D, Kollerits B, Neyer U et al (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18(9):2600-2608 (Pubitemid 47378877)
22. Gutierrez OM, Mannstadt M, Isakova T et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584-592
23. Seiler S, Cremers B, Rebling NM et al (2011) The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J 32(21):2688-2696
24. Jean G, Terrat JC, Vanel T et al (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transpl 24:2792-2796
25. Isakova T, Xie Huiliang, Yang Wei et al (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305(23):2432-2439
26. Stubbs JR, Liu S, Tang W et al (2007) Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18:2116-2124 (Pubitemid 47041077)
27. Ashikaga E, Honda H, Suzuki H et al (2010) Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients. Ther Apher Dial 14(3):315-322
28. Inaba M, Okuno S, Imanishi Y et al (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. OsteoporosInt 17(10):1506-1513 (Pubitemid 44387485)
29. Taylor EN, Rimm EB, Stampfer MJ, Curhan GC (2011) Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 161(5):956-962
30. Olauson H, Qureshi AR, Miyamoto T et al (2010) Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? Nephrol Dial Transpl 25(9):3033-3038
31. DeLuca S, Sitara D, Kang K et al (2008) Amelioration of the premature aging-like features of FGF-23 knockout mice by genetically restoring the systemic actions of FGF-23. J Pathol 216:345-355
32. Shalhoub V, Shatzen EM, Ward SC et al (2012) FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 122:2543-2553
33. Moe OW (2012) Fibroblast growth factor 23: friend or foe in uremia? J Clin Invest 122:2354-2356
34. Nakanishi S, Kazama J, Nii-Kono T et al (2005) Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 67:1171-1178 (Pubitemid 41623344)
35. Schoppet M, Hofbauer LC, Brinskelle-Schmal N et al (2012) Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. J Clin Endocrinol Metab 97(4):E575-E583
36. Coen G, De Paolis P, Ballanti P et al (2011) Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23. J Nephrol 24(3):313-321
37. Tamei N, Ogawa T, Ishida H et al (2011) Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis. J Atheroscler Thromb 18:217-223
38. Kojima F, Uchida K, Ogawa T et al (2008) Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol 40:1067-1074